2014 ACR/ARHP Annual Meeting Archives - Page 202 of 202

Abstract Number: 2031

Early Adherence to Methotrexate in Rheumatoid Arthritis (RA) Is High: a Prospective Longitudinal Study of New Users
Abstract Number: 1554

Early and Sustained Modified Psarc Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from 2 Phase 3 Studies
Abstract Number: 1335

Early Birds Versus Night Owls: Morning/Evening Preference and Its Association with Sleep Problems, Fatigue, and Emotional Well-Being Among RA Patients
Abstract Number: 1688

Early Detection of Left Ventricular Morphological, Functional Abnormalities and Myocardial Characteristics in Systemic Sclerosis without Cardiac Symptoms Using Cardiac Magnetic Resonance Imaging: A Preliminary Report
Abstract Number: 250

Early Gout Pain Response at 28 Hours Predicts Response at 5 Days on Both Patient Pain and Physician Global Assessment
Abstract Number: 796

Early Halo Sign Features on Ultrasound Examination of Treated Patients with Giant Cell Arteritis
Abstract Number: 723

Early Mortality in Australian, Canadian and Spanish Scleroderma Patients: Rationale for Establishing a Multi-National Inception Cohort of Patients with Systemic Sclerosis
Abstract Number: 1891

Early MRI Endpoints Provide a Valid Measure of Structural Damage While Reducing Study Duration and Participant Numbers in Rheumatoid Arthritis Clinical Trials
Abstract Number: 2903

Early Outcomes in Pediatric Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV)
Abstract Number: 2499

Early Response Indicator early Predicts Clinical Response to Certolizumab in Rheumatoid Arthritis Patients
Abstract Number: 2503

Early Response to Full-Dose Etanercept-Plus-Methotrexate Induction Therapy Predicts Sustained Remission with Reduced-Dose Combination Therapy in Early Rheumatoid Arthritis Patients
Abstract Number: 2349

Early Sympathectomy Inhibits Egress of Lymphocytes in Control and Arthritic Animals and Ameliorates Arthritic Disease
Abstract Number: 2407

Early Treatment in Rheumatoid Arthritis and Its Effect on Patient Outcomes
Abstract Number: 1929

Echocardiographic Phenomics for Novel Classification of Cardiac Involvement in Systemic Sclerosis
Abstract Number: 1544

Economic and Comorbidity Burden Among Moderate-to-Severe Psoriasis Patients Comorbid with Psoriatic Arthritis
Abstract Number: 1595

Economic Evaluation of Sequencing Strategies in the Treatment of Psoriatic Arthritis in the United States
Abstract Number: 1155

Economic Impact of Frequent Gout Flares in a Managed Care Setting
Abstract Number: 1144

Economic Implications for Policies Regarding Triple Therapy Use in Patients with Rheumatoid Arthritis
Abstract Number: 1147

Economic Implications of Flares Among Patients with Early Rheumatoid Arthritis (RA)
Abstract Number: 1973

Ectopic Lymphoid Neogenesis Is Strongly Associated with Activation of the IL-23/IL-17 Pathway in Rheumatoid Synovitis
Abstract Number: 13

Eculizumab in Antiphospholipid Antibody Syndrome
Abstract Number: 2195

Eculizumab Treatment of Malignant Atrophic Papulosis (Köhlmeier-Degos Disease): World Experience to Date
Abstract Number: 2858

Education Effects on Outcome Expectations for Exercise in Adults with Knee Osteoarthritis
Abstract Number: 1375

Educational Level and Not Ethnicity an Important Determinant of Disease Progression in Patients with Rheumatoid Arthritis
Abstract Number: 512

Effect and Safety of Concomitant Methotrexate and Tacrolimus on Clinical Response of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Biological Dmards
Abstract Number: 2028

Effect of Age at Rheumatoid Arthritis Onset on Clinical, Radiographic, and Functional Outcomes: The Espoir Cohort
Abstract Number: 179

Effect of Allopurinol on All-Cause Mortality in Adults with Incident Gout: Propensity Score Matched Landmark Analysis
Abstract Number: 2854

Effect of Apremilast on Quality of Life and Physical Function in Patients with Behçet’s Syndrome
Abstract Number: 565

Effect of Certolizumab Pegol over 96 Weeks of Treatment on Inflammation of Spine and Sacroiliac Joints Measured By Magnetic Resonance Imaging in Patients with Axial Spondyloarthritis
Abstract Number: 687

Effect of Corticosteroid Use By Dose on the Risk of Developing Organ Damage over Time in Systemic Lupus Erythematosus—the Hopkins Lupus Cohort
Abstract Number: 1847

Effect of Disease Duration on Clinical Outcomes in Moderate Rheumatoid Arthritis Patients Treated with Etanercept Plus Methotrexate in the Preserve Study
Abstract Number: 619

Effect of ERAP1 Knockdown on Conformation of HLA-B27 and Other HLA Class I Molecules in Human Monocytic Cells
Abstract Number: 337

Effect of Etanercept on Endothelial Dysfunction in Rat Adjuvant-Induced Arthritis
Abstract Number: 64

Effect of Family Support on Short-and Intermediate Term Pain and Function Outcomes after Knee or Hip Replacement
Abstract Number: 2522

Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations
Abstract Number: 1603

Effect of Methotrexate on the Immunogenicity of TNF Inhibitors in Spondyloarthritis Patients
Abstract Number: 2783

Effect of Synovitis, Effusion and Bone Marrow Lesions on Development of Sensitization in Knee OA: The Multicenter Osteoarthritis Study
Abstract Number: 2471

Effect of Teriparatide in Patients with Osteoporosis and Rheumatoid Arthritis
Abstract Number: 2253

Effect of Teriparatide in Patients with Osteoporosis with Prior Vertebral Fracture
Abstract Number: 182

Effect of Urate-Lowering Therapy on Radiographic Changes in Gout Patients
Abstract Number: 2552

Effectiveness and Safety of Low-Dose Cyclosporine a in Patients with Primary Sjögren’s Syndrome (pSS) with Articular Involvement – Results of a Pilot Study
Abstract Number: 2467

Effectiveness and Safety of Tocilizumab in Biologics NaÃ¯ve RA Patients – Interim Analysis of PMS for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-NaÃ¯ve RA Patients Study
Abstract Number: 2128

Effectiveness of ¹⁸f-Fluoro-Dexoxyglucose Positron Emission Tomography for the Diagnosis of Polymyalgia-like Illness
Abstract Number: 2780

Effectiveness of a Sequential Treatment with Intravenous Prostaglandins Followed By Bosentan in Patients with Buerger Disease and Severe Ischemic Lesions: A Case Series
Abstract Number: 2104

Effectiveness of a Workplace Integrated Care Intervention on Work Productivity in Workers with Rheumatoid Arthritis
Abstract Number: 2366

Effectiveness, Tolerability, and Safety of Subcutaneous Methotrexate in Early Rheumatoid Arthritis: Clinical Data from the St. Gallen Cohort
Abstract Number: 916

Effects of 2 Years of Treatment with Romosozumab Followed By 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density
Abstract Number: 2965

Effects of Anti-NGF Strategies in Two Animal Models of Osteoarthritis (OA)
Abstract Number: 2750

Effects of Anticoagulant Treatment on the Incidence of New Vascular Events in Patients with Behcet’s Disease with Vascular Involvement
Abstract Number: 2836

Effects of Blisibimod, an Inhibitor of B Cell Activating Factor, on Patient Reported Outcomes and Disease Activity in Patients with Systemic Lupus Erythematosus
Abstract Number: 684

Effects of Current Therapies for Lupus on Disease Activity and Renal Flares
Abstract Number: 2260

Effects of Daily Teriparatide on the Spine and Femoral Strength Assessed By Finite Element Analysis of Clinical Computed Tomography in Rheumatoid Arthritis Patients
Abstract Number: 2916

Effects of Exercise on Body Composition, Cardiovascular Fitness, Muscle Strength, and Cognition in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial of a Patient-Specific Exercise Programme
Abstract Number: 67

Effects of Exercise on Depressive Symptoms in Adults with Arthritis: A Systematic Review with Meta-Analysis
Abstract Number: 2242

Effects of Intraarticular (IA) Corticosteroid Injections on Bone Markers and Endogenous Cortisol in Patients with Knee Osteoarthritis (OA): A Randomized, Double-Blind, Placebo Controlled Trial
Abstract Number: 1938

Effects of Mesenchymal Stem Cells on Human B Cell Proliferation
Abstract Number: 2915

Effects of Methotrexate on Anti-TNF Treatment in Rheumatoid Arthritis: An in-Depth Analysis of a Prospective Observational Study with Adalimumab
Abstract Number: 1685

Effects of Mycophenolate Mofetil on Pulmonary Lung Function in Interstitial Lung Disease of Systemic Sclerosis
Abstract Number: 2256

Effects of Pre-Dosage Alendronate Treatment on Bone Metabolic Indices and Bone Mineral Density in Patients Treated with Glucocorticoids: A Prospective Study
Abstract Number: 2591

Effects of Self-Management Model on the Disease-Related Knowledge, Joint Function and Quality of Life in Patients with Ankylosing Spondylitis
Abstract Number: 1181

Effects of Tofacitinib on Bone Marrow Edema, Synovitis, and Erosive Damage in Methotrexate-Naïve Patients with Early Active Rheumatoid Arthritis (Duration ≤2 Years): Results of an Exploratory Phase 2 MRI Study
Abstract Number: 2487

Effects of Tofacitinib on Health Care Resource Utilization and Work Productivity in US Patients with Rheumatoid Arthritis
Abstract Number: 507

Efficacy and Safety of Adalimumab Therapy in Japanese Patients with Rheumatoid Arthritis
Abstract Number: 2757

Efficacy and Safety of ANTI-TNF ALPHA in BEHÇET Disease: A International Multicenter Registry of 122 Patients
Abstract Number: 1483

Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients during a 52 Week Extension Phase
Abstract Number: 175

Efficacy and Safety of Canakinumab in Acute Gouty Arthritis Patients with Chronic Kidney Disease Stage Greater Than or Equal to 3: A Post-Hoc Analysis of 12-Week Data
Abstract Number: 264

Efficacy and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials
Abstract Number: 481

Efficacy and Safety of Etanercept in Rheumatoid Arthritis Patients over 75 Years Old
Abstract Number: 2269

Efficacy and Safety of High Dose Infliximab in the Treatment of Uveitis in Pediatric Patients
Abstract Number: 1793

Efficacy and Safety of IFN-Alpha in Induction and Maintenance of Remission in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA). Single Center Observational Study
Abstract Number: 1497

Efficacy and Safety of Iguratimod for Rheumatoid Arthritis
Abstract Number: 496

Efficacy and Safety of Induction Therapy for Rheumatoid Arthritis with Simultaneous Administration of Methotrexate and Low-Dose Tacrolimus: A Retrospective Study
Abstract Number: 1528

Efficacy and Safety of MK-8457, a Novel SYK Inhibitor for the Treatment of Rheumatoid Arthritis in Two Randomized, Controlled, Phase 2 Studies
Abstract Number: 947

Efficacy and Safety of NNC01140006, an Anti-IL-21 Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis
Abstract Number: 2855

Efficacy and Safety of Rituximab Retreatment Regimen at Clinical Relapse in Severe Cryoglobulinemic Vasculitis
Abstract Number: L25

Efficacy and Safety of Subcutaneous Tabalumab in Patients with Systemic Lupus Erythematosus (SLE): Results from 2 Phase 3, 52-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trials
Abstract Number: 493

Efficacy and Safety of Tofacitinib Following Inadequate Response to Nonbiologic DMARD or Biologic DMARD
Abstract Number: 539

Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
Abstract Number: 497

Efficacy and Safety Study of a Sequential Therapy of Tocilizumab and, If Initially Inadequately Responded to Tocilizumab, Followed By Rituximab in Patients with Rheumatoid Arthritis and Inadequate Response to Traditional Disease Modifying Anti-Rheumatic Drugs
Abstract Number: 2821

Efficacy and Safety/Tolerability of Mavrilimumab, a Human GM-CSFRÃ¡ Monoclonal Antibody in Patients with Rheumatoid Arthritis
Abstract Number: 2474

Efficacy and Tolerability of Subcutaneous Methotrexate for Inflammatory Arthritis: A Retrospective Observational Cohort Study
Abstract Number: 2528

Efficacy Meta-Analysis of Randomized Controlled Trials (RCTs) of Biologics in Methotrexate-Naive Patients with Early Rheumatoid Arthritis
Abstract Number: 2354

Efficacy of a Novel Orally Bioavailable JAK1 Selective Compound in a Preclinical Rat Collagen-Induced Arthritis Model
Abstract Number: 1240

Efficacy of Anakinra in Refractory Adult-Onset Still´s Disease: Multicenter Study of 41 Patients
Abstract Number: 879

Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Rapidly Progressive Systemic Sclerosis: Prolonged Remission of Disease Activity in a Long-Term Follow up
Abstract Number: 2419

Efficacy of Biologic Medications in Active Rheumatoid Arthritis: A Systematic Review
Abstract Number: 1527

Efficacy of Biologic Treatments in Early Active Rheumatoid Arthritis: An Indirect Comparison
Abstract Number: 2526

Efficacy of Biological Therapies in Rheumatoid Arthritis: Graphical Modeling of DAS28 Components’ Evolution over Time
Abstract Number: 2297

Efficacy of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) using JADAS Criteria – an Analysis of 12-Week Pooled Data
Abstract Number: 1251

Efficacy of Certolizumab in Patients with Refractory Uveitis to Other Biologic Therapy. Study of 7 Cases
Abstract Number: 2371

Efficacy of First Line Biological Monotherapy in RA: Data from the Czech Registry Attra
Abstract Number: 2529

Efficacy of Infliximab, Adalimumab, and Tocilizumab Can be Improved Under the Baseline ADAMTS5 Selection
Abstract Number: 1230

Efficacy of Interleukin-1 Targeting Drugs in Familial Mediterranean Fever Patients
Abstract Number: 2239

Efficacy of Ketoprofen Lysine Salt in Reducing Inflammation and Pain in Primary Osteoarthritis of the Hand: Preliminary Results of a Retrospective and Prospective Clinical Trial
Abstract Number: 2433

Efficacy of Ketoprofen Vs Ibuprofen and Diclofenac for Treating Pain in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Abstract Number: 1532

Efficacy of the Subcutaneous Formulation of Abatacept/Orencia in Rheumatoid Arthritis, a Single-Center Italian Experience
Abstract Number: 1179

Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: Sequential Evaluation Using Whole-Body Magnetic Resonance Imaging
Abstract Number: 1249

Efficacy of Tocilizumab in Patients with Uveitis Refractory to Other Biologic Drugs: A Multicenter Study on 31 Cases
Abstract Number: 1241

Efficacy of Tocilizumab Therapy in Korean Patients with Adults Onset Still’s Disease: Multicenter Retrospective Study of 20 Cases
Abstract Number: 2133

Efficacy of Tocilizumab Therapy in Patients with Rheumatoid Arthritis Based on FDG-PET/CT
Abstract Number: 1665

Efficacy Versus Safety of Prednisone in Lupus Nephritis Since 1988
Abstract Number: 2081

Ehlers-Danlos Hypermobile (EDS-HT) Patients and Postural Instability : Another Clue to Explain Pain and Fatigue ?
Abstract Number: 1344

Electronic Medical Record-Based Best Practice Alert Used By Clinical Staff Improved Pneumococcal Vaccination and Documentation Among Immunosuppressed Rheumatoid Arthritis Patients
Abstract Number: 2057

Electrophysiological Evaluation of Autonomic Nervous System and Cutaneous Silent Period in Patients with Fibromyalgia Syndrome
Abstract Number: 313

Elevated Cardiovascular Disease Burden and Inflammatory Biomarker Levels in Adults with Juvenile Idiopathic Arthritis
Abstract Number: 1799

Elevated Indoleamine-2,3-Dioxygenase (IDO) Activity and Kynurinene-3-Monooxygenase (KMO) Expression in Interferon Positive Primary Sjogrens Syndrome Patients Is Associated with Increased CD25^hiFoxP3⁺regulatory Tcells: A Skew Towards Neurotoxicity or an Attempt to Rescue?
Abstract Number: 1004

Elevated Levels of BMP2 Compensate for Loss of TGF-Beta in Articular Cartilage during Experimental Osteoarthritis
Abstract Number: 2880

Elevated Levels of Soluble Inflammatory Mediators and Lupus-Specific Connective Tissue Disease Questionnaire Scores Discern Unaffected First Degree Relatives of Lupus Patients from Unaffected Individuals Not Related to Lupus Patients
Abstract Number: 746

Elevated Pentraxin 3 in Patients with Systemic Sclerosis: Associations with Vascular Manifestations and Defective Vasculogenesis
Abstract Number: 81

Elevated Peripheral Blood Leukocyte Inflammatory Gene Expression in Radiographic Progressors with Symptomatic Knee Osteoarthritis: NYU and OAI Cohorts
Abstract Number: 1605

Elevated Regulatory Mediators and Interferon Gamma Associated Responses, but Not Interferon Alpha, BLyS or IP-10, Accompany High-Titer Anti-Ro Autoantibodies in Asymptomatic Mothers of Children with Neonatal Lupus
Abstract Number: 2200

Elevated Serum Ferritin Levels in Adult Inpatients As a Predictor of in-Hospital Mortality and Association with Macrophage Activation Syndrome
Abstract Number: 2070

Elevated Serum Leptin Concentrations in a Subset of Fibromyalgia Patients with High Inflammatory Markers
Abstract Number: 2703

Elevated Serum Levels of Endostatin in Mixed Connective Tissue Disease – Association with Pulmonary Fibrosis and Digital Ulcers
Abstract Number: 1976

Elevation and Functional Activity of Interferon Omega in Human Systemic Lupus Erythematosus
Abstract Number: 2972

Elevations of Certain Memory-Effector T Cell and Inflammatory Monocyte Subpopulations in Rheumatoid Arthritis Are Associated with the Presence of Subclinical Coronary Artery Atherosclerosis
Abstract Number: 1952

Elucidation of Molecular Mechanisms of Breg Induction in Autoimmune Diseases
Abstract Number: 1547

Endocrine Co-Morbidities in Patients with Psoriatic Arthritis: A Population-Based Study
Abstract Number: 2218

Endoplasmic Reticulum (ER) Stress-Induced Mitochondrial Dysfunction and Atrophy Can be Prevented By Pharmacological Upregulation of Heat Shock Protein 70 (HSP) in Cultured Murine Myotubes
Abstract Number: 1699

Endothelial and Platelet Microparticles As Potential Novel Biomarkers of Peripheral Microvascular Dysfunction in Systemic Sclerosis and Primary Raynaud’s Phenomenon
Abstract Number: 766

Endothelial Fli1 Deficiency Delays Wound Healing Due to Impaired Anastomosis of Newly Formed Vessels – a Possible Mechanism of Refractory Skin Ulcers in Systemic Sclerosis
Abstract Number: 1717

Endothelial to Mesenchymal Transition Contributes to the Development of Pulmonary Vasculopathy in Systemic Sclerosis PAH
Abstract Number: 1710

Endothelin-1 Is a Downstream Mediator of Profibrotic Effects by Transforming Growth Factor-β1 in Systemic Sclerosis Skin Fibroblasts
Abstract Number: 774

Endothelin-1 Synergistically Increases TGF-β-Induced Hif1α Expression Under Normoxic Conditions during Endothelial-to-Mesenchymal Transition in Murine Endothelial Cells. a Novel Mechanism for the Fibrogenic Effects of Endothelin
Abstract Number: 649

Enhance Translatability Using Multi-Modality Disease Evaluation Approach in Lupus Model
Abstract Number: 2362

Enhanced Efficacy of Dexamethose with Synovial Fibroblast Targeted Micelles in a Collagen-Induced Arthritis Mouse Model
Abstract Number: 2725

Enhanced Expression of CCL25 to Facilitate Increased Numbers of CCR9-Expressing Tfh-like Cells in Salivary Glands of Primary Sjögren’s Syndrome Patients
Abstract Number: 1223

Enhancement of Proinflammatory Cytokine Production By Uric Acid in Human Cells Via Down Regulation of IL-1Ra
Abstract Number: 275

Environmental Risk Factors and Development of Juvenile Idiopathic Arthritis
Abstract Number: 1758

Environmental Risk Factors for Granulomatous Polyangiitis (GPA): Southern Hemisphere Similar to Northern Hemisphere
Abstract Number: 1258

Enzyme-Linked Immunosorbent Assays for Detection of Anti-Transcriptional Intermediary Factor-1 Gamma and Anti-Mi-2 Autoantibodies in Dermatomyositis: Utility and Crossreactivity
Abstract Number: 2211

Epidemiologic and Clinical Features of Patients with Adult and Juvenile Dermatomyositis, Polymyositis and Inclusion Body Myositis from Myovision, a National Myositis Patient Registry
Abstract Number: 1269

Epidemiology and Characteristics of Antisynthetase Syndrome in the African Descent Population of Martinique
Abstract Number: 60

Epidemiology of Polymyalgia Rheumatica in Korea
Abstract Number: 2879

Epigallocatechin-3-Gallate (EGCG) Suppresses IL-1β-Induced IL-6 and IL-8 Synthesis By Selectively Inhibiting TAK1 Activation in Human Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 623

Epigenetic Studies in Maternally Versus Paternally Transmitted Psoriatic Disease
Abstract Number: 2101

Epigenetic Study of Advanced Ankylosis in Patients with Ankylosing Spondylitis
Abstract Number: 77

Epigenome Profiling Reveals Robust Hypomethylation of Interferon Signature Genes in Lupus Neutrophils
Abstract Number: 2873

Epratuzumab Induces Broad Inhibition of B Cell Receptor Proximal Signaling but Has Opposing Effects on Distal Signaling in B Cell Subsets: A Profile of Effects on Functional Immune Signaling By Single Cell Network Profiling
Abstract Number: 621

ERAP1 Knockdown Affects HLA-B27 Misfolding and Endoplasmic Reticulum Stress in HLA-B27 Transgenic Rat Macrophages
Abstract Number: 764

ERG and FLI1 in Systemic Sclerosis-Associated Pulmonary Complications
Abstract Number: 1192

Erosions Detected By Magnet Resonance Imaging in Patients with Juvenile Idiopathic Arthritis (JIA) Are True Erosions As Visualized By Computed Tomography
Abstract Number: 1608

Erythrocyte C4d and Antibodies to Anti-C1q Are Associated with Proteinuria in Lupus Nephritis
Abstract Number: 3005

Essential Role for Alternately Spliced Tenascin C and TLR4 Signaling in Persistent Organ Fibrosis
Abstract Number: 288

Establishing Clinical Meaning and Defining Important Differences in Patient Reported Outcome Measures of Physical Function, Fatigue and Pain Interference in Juvenile Idiopathic Arthritis
Abstract Number: 494

Estimation of Cost per Effectively Treated Patients with Biologic Disease Modifying Anti-Rheumatic Drugs in US Veterans with Rheumatoid Arthritis
Abstract Number: 2687

Estrogen-Mediated STAT1 Activation By Estrogen Receptor a Induces TLR8 Expression: A Novel Pathogenic Mechanism in Systemic Lupus Erythematosus
Abstract Number: 509

Etanercept Have Better Drug Survival Than Monoclonal Antibodies in Rheumatoid Arthritis: Results of Single Center Hur-BIO Registry
Abstract Number: 2414

Etanercept in Mono Therapy or in Combination with MTX: Results from a Sub Analysis of a German Non-Interventional Study
Abstract Number: 2558

Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures
Abstract Number: 328

Etanercept, Abatacept and Anakinra Treatment Ameliorates Inflammation and Pain in a Novel Mono-Arthritic Multi-Flare Model of Streptococcal Cell Wall Induced Arthritis: Further Characterization in a Rodent Model of Collagen Induced Arthritis
Abstract Number: 2378

Ethnic Minorities with Rheumatoid Arthritis Achieve a Meaningful Clinical Response at 12 Months Despite Infrequent Use of Biologic Therapies
Abstract Number: 2589

EULAR Recommendations for the Use of Imaging in Spondyloarthritis in Clinical Practice
Abstract Number: 1152

Euroqol-5-Dimensions Utility Gain in Rheumatoid Arthritis, Treated with Abatacept, Rituximab, Tocilizumab or Tumor Necrosis Factor Inhibitors
Abstract Number: 1174

Evaluating MRI-Detected Tenosynovitis of the Hand and Wrist in Early Arthritis
Abstract Number: 253

Evaluating Neuropathic Complaints By DN4 and Lanss Scales after Local Corticosteroid Therapy in Carpal Tunnel Syndrome
Abstract Number: 2336

Evaluating the Use of Video-Stimulated Recall to Research the Osteoarthritis Consultation in Primary Care: Reaching Parts Other Methods don’t Reach
Abstract Number: 1148

Evaluation of a Methodological Approach to Determine Timing of Rheumatoid Arthritis Disease Onset Using Administrative Claims Data
Abstract Number: 1177

Evaluation of a Simplified Version of the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) Comprising 5 Joints (RAMRIS5)
Abstract Number: 1145

Evaluation of Biologic Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Post-Tumor Necrosis Factor Inhibitor Discontinuation in Rheumatoid Arthritis
Abstract Number: 563

Evaluation of Clinical Parameters and Quality of Life in Smokers with Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing Spondylitis
Abstract Number: 1558

Evaluation of Extreme Enthesitis and/or Patient-Related Outcome Score As Potential Surrogates for Fibromyalgia and As Potential Confounding Factors of Anti-TNF Response
Abstract Number: 917

Evaluation of Invasive Oral Procedures and Events in Women with Postmenopausal Osteoporosis Treated with Denosumab: Results from the Pivotal Phase 3 Fracture Study Extension
Abstract Number: 2852

Evaluation of KIR3DL1/KIR3DS1 Association with Behçet’s Disease in Turkish Individuals
Abstract Number: 137

Evaluation of Metalloproteinase-3 As a Soluble Biomarker of Synovitis Using Weighted Joint Counts Assessed Clinically and on Ultrasound Imaging
Abstract Number: 2402

Evaluation of Perceived Self-Efficacy, Learned Helplessness and Functional Capacity in Patients with Rheumatoid Arthritis
Abstract Number: 375

Evaluation of RAPID3 with Minimal Joint Count and ACR/EULAR Provisional Remission Definitions As Predictors of Future Good Radiographic + Functional Outcome in a Double-Blind, Phase 3, Randomized Controlled Trial of Tocilizumab
Abstract Number: 100

Evaluation of Real World Experience with Non-Biologic DMARD in the Treatment of RA: Data from an Electronic Health Record Database
Abstract Number: 2937

Evaluation of Referral Models for Axial Spondyloarthritis in Primary Care in the Spondyloarthritis Caught Early Cohort
Abstract Number: 1165

Evaluation of Symptom Control Among Treated Gout Patients in the United States, United Kingdom, and Germany
Abstract Number: 459

Evaluation of the Effect of Tofacitinib on Measured Glomerular Filtration Rate in Patients with Active Rheumatoid Arthritis
Abstract Number: 3015

Evaluation of the effuc Educational Needs Assessment Tool (ENAT) Focused Patient Education on Health Outcomes in Patients with Rheumatolid Arthritis – a Randomised Controlled Trial
Abstract Number: 581

Evaluation of the Nonsteroidal Anti-Inflammatory Drug-Sparing Effect of Etanercept in Axial Spondyloarthritis: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Abstract Number: 1584

Evaluation of the Patient Acceptable Symptom State in Patients with Psoriatic Arthritis
Abstract Number: 1529

Evaluation of the Pharmacokinetics and Safety of the Interactions Between the Anti-Interleukin-6 Monoclonal Antibody Sirukumab and Cytochrome P450 Activities in Patients with Rheumatoid Arthritis
Abstract Number: 467

Evaluation of the Rabbit Risk Score for Serious Infections in a UK Anti-TNF Treatment Cohort
Abstract Number: 2083

Evaporative Dry-Eye Disease and Aqueous Deficient Dry-Eye Disease Associated with Fibromyalgia
Abstract Number: 1841

Eventual Joint Failure and Surgery Rates in Rheumatoid Arthritis Remain High in Patients with Moderate Disease Activity in the First 5 Years of Disease
Abstract Number: 2282

Evidence Based Recommendatinos for Diagnosis and Management of Mevalonate Kinase Deficiency (MKD)
Abstract Number: 2279

Evidence Based Recommendations for Diagnosis and Management of Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS)
Abstract Number: 1231

Evidence Based Recommendations for Genetic Diagnosis of Familial Mediterranean Fever
Abstract Number: 2280

Evidence Based Recommendations for the Management of Cryopyrin Associated Periodic Syndromes (CAPS)
Abstract Number: 444

Evidence for Citrullination of the Nuclear Transciption Factor Inhibitor of DNA Binding 1 (Id1) in Rheumatoid Arthritis
Abstract Number: 28

Evidence for Receptor Activator of NF-Kb (RANK)-Independent Bone Erosion in the Cherubism Mouse Model of Inflammatory Arthritis
Abstract Number: 1263

Evidence for the Involvement of NK Cells in Antisynthetase Syndrome
Abstract Number: 668

Evolution of Patients with Systemic Lupus Erythematous Treated with Belimumab in Clinical Practice Settings
Abstract Number: 1455

Ex Vivo-Expanded, but Not in Vitro-Induced, Human Regulatory T Cells Are Suitable for Cell Therapy in Rheumatological Autoimmune Diseases Thanks to Stable FOXP3 Demethylation
Abstract Number: 1882

Examination of Patients Newly Diagnosed with Fibromyalgia: Use of Guideline-Recommended Therapies and Opioids in Clinical Practice
Abstract Number: 1934

Examing Why Minority Women Are Risk Averse : A Qualitative Study
Abstract Number: 843

Exercise Is Associated with Protective Cardiovascular Risk Profile Including Increased HDL Particle Number in Patients with Rheumatoid Arthritis
Abstract Number: 2897

Exercise Therapy and/or Manual Therapy for Hip or Knee Osteoarthritis: 2-Year Follow-up of a Randomized Controlled Trial
Abstract Number: 889

Exercise, Manual Therapy, and Use of Booster Sessions in Physical Therapy for Knee OA: A Multi-Center Randomized Clinical Trial
Abstract Number: 2838

Exploratory Analysis of Pharmacokinetic Effects of Atacicept in Patients with Moderate to Severe Systemic Lupus Erythematosus
Abstract Number: 2238

Exploratory Six Month Phase IIa Study of a Potential Disease Modifying Drug in Patients with OA of the Knee
Abstract Number: 997

Explore Translational Pharmacokinetics/Pharmacodynamics Response/Efficacy Relationship of a Novel Bruton’s Tyrosine Kinase Inhibitor in Rat Collagen-Induced Arthritis Model
Abstract Number: 1591

Exploring the Association of Serum Paraoxonase and Arylesterase Activities with Cardiovascular Risk in Psoriasis and Psoriatic Arthritis
Abstract Number: 426

Exploring the DAS: What Is the Level of Agreement in the Classification of Remission and Low Disease Activity (LDA) Among the Various Versions of the Disease Activity Score (DAS) and Their Correlation? an Analysis from a Prospective, Observational Registry
Abstract Number: 1496

Exposure-Response Analysis for Mavrilimumab Phase2b Study in RA Patients with Informative Dropout
Abstract Number: 531

Expression of Indoleamine 2,3 Dioxygenase-1 and -2 in Focal Sialoadenitis of Patients with Sjögren’s Syndrome
Abstract Number: 1205

Expression of Lectin-like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis
Abstract Number: 2178

Extensive Natural Killer Cell Receptor Phenotyping on NK and T Cells Discloses Differences in RA and Psa, Potentially Mirroring Diverse Immunoregulatory Functions
Abstract Number: 828

Extent of Urate Deposition in Asymptomatic Hyperuricemia and Symptomatic Gout: A Dual Energy Computed Tomography Study
Abstract Number: 215

External Hip Adduction Moment and Progression of Medial Tibiofemoral Cartilage Damage and Bone Marrow Lesions in Persons with Knee Osteoarthritis
Abstract Number: 2866

External Validation of the Global Anti-Phospholipid Syndrome Score in Comparison to IgG Antibodies Directed Against Domain I of ß₂-Glycoprotein I. a Prospective Multicentre Cohort Study
Abstract Number: 2168

Extramedullary Myelopoiesis Drives Persistent Toll-like Receptor-Mediated Inflammation